The National Pharmaceutical Council (NPC) is pleased to be joining other leading health care organizations at ISPOR 2022, the premier global conference for health economics and outcomes research. NPC experts will be presenting their research, contributing important data to conversations about fostering an environment in the United States that supports medical innovation.
On, Monday, May 16 at 6:00 pm ET, join Michael Ciarametaro, NPC Vice President, Research, for a special student session and networking event where he will present and discuss NPC’s new Health Care Spending Guiding Principles. The continued rise in health care spending and patient out-of-pocket costs in the United States has led to an intense debate among policymakers and other health care stakeholders on managing increasing costs. NPC developed these principles with the intention of guiding a rigorous, evidence-based evaluation and discussion of health care spending estimates and policies to improve health care spending efficiency and maximize patient health.
A student networking reception will be hosted immediately following the presentation and will be a great opportunity for students attending the conference to network with peers and professionals in the field.
Ciarametaro also will participate in an important panel discussion, “Could Gene Therapy Value-Based Purchasing Become Common Thanks to the New CMS Rule on Medicaid Best Price?” on Tuesday, May 17 at 10:15 am ET.
The session will outline the use of alternative payment approaches to manage financial risk associated with curative therapies, explain how a 2021 Centers for Medicare and Medicaid Services rule could lead to widespread adoption of Value-Based Purchasing Arrangements, and detail the remaining challenges. The panel will also explore how those challenges can be overcome by a combination of clever implementation and eventually, reforms to the Medicaid Drug Rebate Program.
Connect with Us
You are invited to stop by the NPC booth (#221) to meet the NPC team, for one-on-one discussions with us to explore our latest data and findings and gather insight into our ongoing research projects.
If you are not attending the conference in person but would still like important information on NPC presentations and updates, be sure to connect with NPC leaders on Twitter and LinkedIn.
John M. O'Brien, PharmD, MPH, President and CEO, NPC
Twitter: @drjmob | LinkedIn: John O'Brien
Sharon Phares, PhD, MPH, Chief Scientific Officer, NPC
Twitter: @SEPhares | LinkedIn: Sharon Phares
Michael Ciarametaro, MBA
Twitter: @mikeciarametaro | LinkedIn: Mike Ciarametaro